Procter & Gamble Hygiene and Health Care Limited — Investor Meet, 16-06-2026: Analysts/Institutional Investor Meet/Con. Call Updates

P&G Hygiene reported FY26 sales flat at ~₹4300 Cr, but PAT surged 19% to ~₹850 Cr, driven by targeted savings of ₹86 Cr. Over the past decade, sales have seen mid-single-digit growth, with profits growing at an 8% CAGR and ROE tripling.

Management highlighted an integrated strategy focusing on product superiority, productivity, and constructive disruption. Whisper Period Panties excelled, selling 10 Cr units and tripling business, while Vicks introduced significant product upgrades.

Despite evolving consumer demands, intense competition, and macro headwinds, the company maintains market leadership in Feminine Care and Healthcare. Their focus remains on consumer-first innovation and balanced growth, reflecting a confident long-term outlook.